What is the brand name for Doxepn?

Doxepn is sold under the brand name Doxepin Hydrochloride.

Is Doxepin Hydrochloride the same as Doxepn?

Yes. Doxepin Hydrochloride is a brand name for Doxepn. The generic version is identical in active ingredient, dose, and FDA-approved indications. Pricing differs substantially: generic Doxepn typically prices well below brand Doxepin Hydrochloride.

When was Doxepn first FDA approved?

Doxepn received its first FDA approval on 2021-06-01.

Doxepn (Doxepin Hydrochloride) — Plan cost, generics, alternatives

At a glance · the numbers a plan sponsor wants on screen one

Lowest NADAC

$0.270/unit

1 NDCs benchmarked, lowest of all strengths.

Average NADAC

$0.270

Across all dosage forms in distribution.

Highest NADAC

$0.270

Range is tight.

Plans with PA

0 / 329

Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible

What is Doxepn used for?

Doxepn is a this drug class medication tracked in Medicare Part D.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

Is there a generic for Doxepn?

No. Doxepn is brand-only with no generic equivalents currently in market.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

How much does my plan pay for Doxepn?

Across 329 Part D plans, Doxepn averages $0.270/unit (NADAC). Lowest available: $0.270/unit. Highest in distribution: $0.270/unit.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

Is Doxepn on the FDA shortage list?

No. Doxepn is not currently on the FDA Drug Shortage Database.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.

Questions a plan sponsor actually asks.

Related questions.

Sources · every number above traces back.